On Monday, Sept. 17, Indianapolis-based TriMedx announced plans to buy the healthcare technologies division of Aramark Corporation for $300 million. The two companies have signed a definitive agreement and expect the transaction to be completed by the end of the year.

On Monday, Sept. 17, Indianapolis-based TriMedx announced plans to buy the healthcare technologies division of Aramark Corporation for $300 million. The two companies have signed a definitive agreement and expect the transaction to be completed by the end of the year.

On Monday, Sept. 17, Indianapolis-based TriMedx announced plans to buy the healthcare technologies division of Aramark Corporation for $300 million. The two companies have signed a definitive agreement and expect the transaction to be completed by the end of the year.

Aidoc, a Tel-Aviv, Israel-based medical imaging company, announced back in August that it had gained FDA clearance for a new solution that helps radiologists triage patients using artificial intelligence (AI).

Roughly 30 U.S. senators and congressional representatives were sought to cosponsor the CT Colonography Screening for Colorectal Cancer Act of 2017—H.R. 1298—at a Capitol Hill briefing on Wednesday, Sept. 12. The meeting was sponsored by the American College of Radiology (ACR) and the Colorectal Cancer Alliance, according to an ACR press release.

Providing patients with an accurate estimate of out-of-pocket costs before imaging services take place can decrease lost revenue and increase patient satisfaction, according to a new study published in the Journal of the American College of Radiology.

Cigna is launching a venture fund that will be dedicated to investing in companies with innovative and transformative plans for healthcare.

Despite national guidelines advising against prostate cancer screening in men 70 or older, researchers from the University of North Carolina (UNC) Lineberger Comprehensive Cancer Center found that prostate cancer care for this demographic costs Medicare more than $400 million a year, according to a study published Sept. 13 in JAMA Oncology.